This article was published on August 4, 2015

The FDA has approved the first drug designed using 3D-printing technology


The FDA has approved the first drug designed using 3D-printing technology
Nate Swanner
Story by

Nate Swanner

Former Reporter, TNW

TNW's former West Coast writer in the PNW (Portland, Oregon). Nate loves amplifying developers, and codes in Swift when he's not writing. If TNW's former West Coast writer in the PNW (Portland, Oregon). Nate loves amplifying developers, and codes in Swift when he's not writing. If you need to get in touch, Twitter is your best bet.

The FDA has just approved the world’s first 3D-printed medication, SPRITAM. The seizure drug is meant to be customized for high dosage treatments, and was developed with Aprecia’s ZipDose technology.

SPRITAM’s 3D-printed designed makes it water soluble with a minimal amount of liquid, which absorbs into the blood stream in less than 10 seconds.“By combining 3DP technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” Don Wetherhold, Aprecia’s Chief Executive Officer of Aprecia, said in a press release

The use of 3D-printing for medical purposes is not new, but this is the first time the FDA has approved a drug designed by 3D-printing.

FDA approves the first 3D printed drug product [Aprecia]

Read next: 3D printing: It’s the future of… something… Wait, what is it?